Dr. Shakeela Bahadur
Claim this profileBanner MD Anderson Cancer Center
Expert in Breast Cancer
Studies Cancer
11 reported clinical trials
29 drugs studied
Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 positive
Stage III
2Cancer
HER2 positive
ER positive
Stage IV
Affiliated Hospitals
Clinical Trials Shakeela Bahadur is currently running
T-DM1 + Tucatinib
for Breast Cancer
This phase III trial studies how well trastuzumab emtansine (T-DM1) and tucatinib work in preventing breast cancer from coming back (relapsing) in patients with high risk, HER2 positive breast cancer. T-DM1 is a monoclonal antibody, called trastuzumab, linked to a chemotherapy drug, called DM1. Trastuzumab is a form of targeted therapy because it attaches to specific molecules (receptors) on the surface of cancer cells, known as HER2 receptors, and delivers DM1 to kill them. Tucatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Giving T-DM1 and tucatinib may work better in preventing breast cancer from relapsing in patients with HER2 positive breast cancer compared to T-DM1 alone.
Recruiting1 award Phase 313 criteria
Imlunestrant
for Early Breast Cancer
This trial is testing a new medication called imlunestrant to see if it works better than standard hormone treatments for certain breast cancer patients. The study focuses on patients with early-stage breast cancer that is estrogen receptor positive and HER2 negative, who have already been on hormone therapy for a period of time and are at high risk of their cancer returning. Imlunestrant works by blocking estrogen from helping cancer cells grow.
Recruiting2 awards Phase 36 criteria
More about Shakeela Bahadur
Clinical Trial Related5 years of experience running clinical trials · Led 11 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Shakeela Bahadur has experience with
- Abemaciclib
- Tucatinib
- Trastuzumab
- Pertuzumab
- Imlunestrant
- Exemestane
Breakdown of trials Shakeela Bahadur has run
Breast Cancer
Cancer
- Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer
- Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy
- T-DM1 + Tucatinib for Breast Cancer
Tumors
Endometrial Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Shakeela Bahadur specialize in?
Shakeela Bahadur focuses on Breast Cancer and Cancer. In particular, much of their work with Breast Cancer has involved Stage IV patients, or patients who are HER2 positive.
Is Shakeela Bahadur currently recruiting for clinical trials?
Yes, Shakeela Bahadur is currently recruiting for 2 clinical trials in Gilbert Arizona. If you're interested in participating, you should apply.
Are there any treatments that Shakeela Bahadur has studied deeply?
Yes, Shakeela Bahadur has studied treatments such as Abemaciclib, Tucatinib, Trastuzumab.
What is the best way to schedule an appointment with Shakeela Bahadur?
Apply for one of the trials that Shakeela Bahadur is conducting.
What is the office address of Shakeela Bahadur?
The office of Shakeela Bahadur is located at: Banner MD Anderson Cancer Center, Gilbert, Arizona 85234 United States. This is the address for their practice at the Banner MD Anderson Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.